These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 27839720)

  • 21. Anxiety and depression in patients with Parkinson's disease.
    Yamanishi T; Tachibana H; Oguru M; Matsui K; Toda K; Okuda B; Oka N
    Intern Med; 2013; 52(5):539-45. PubMed ID: 23448761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occurrence risk and structure of depression in Parkinson disease with and without dementia: results from the GEPAD Study.
    Riedel O; Heuser I; Klotsche J; Dodel R; Wittchen HU;
    J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):27-34. PubMed ID: 20042544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.
    Santos-García D; de la Fuente-Fernández R
    J Neurol Sci; 2013 Sep; 332(1-2):136-40. PubMed ID: 23890935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apathy and Anhedonia: Clinical and Neurophysiological Assessment of a Romanian Cohort.
    Sipos-Lascu D; Vesa ȘC; Perju-Dumbravă L
    Brain Sci; 2021 May; 11(6):. PubMed ID: 34072624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depression and voice handicap in Parkinson disease.
    Sunwoo MK; Hong JY; Lee JE; Lee HS; Lee PH; Sohn YH
    J Neurol Sci; 2014 Nov; 346(1-2):112-5. PubMed ID: 25172195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anxiety rating scales in Parkinson's disease: a validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale.
    Leentjens AF; Dujardin K; Marsh L; Richard IH; Starkstein SE; Martinez-Martin P
    Mov Disord; 2011 Feb; 26(3):407-15. PubMed ID: 21384425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics of apathy in treatment-naïve patients with Parkinson's disease.
    Terashi H; Ueta Y; Kato H; Mitoma H; Aizawa H
    Int J Neurosci; 2019 Jan; 129(1):16-21. PubMed ID: 30035696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apathy and depression in Parkinson's disease: the Belgrade PD study report.
    Ziropadja Lj; Stefanova E; Petrovic M; Stojkovic T; Kostic VS
    Parkinsonism Relat Disord; 2012 May; 18(4):339-42. PubMed ID: 22166396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Motor impairment, depression, dementia: which forms the impression of disease severity in Parkinson's disease?
    Riedel O; Klotsche J; Wittchen HU;
    Parkinsonism Relat Disord; 2014 Dec; 20(12):1365-70. PubMed ID: 25304858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Symptom Dimensions of Depression and Apathy and Their Relationship With Cognition in Parkinson's Disease.
    Szymkowicz SM; Dotson VM; Jones JD; Okun MS; Bowers D
    J Int Neuropsychol Soc; 2018 Mar; 24(3):269-282. PubMed ID: 29032789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depressive symptom profile in Parkinson's disease: a comparison with depression in elderly patients without Parkinson's disease.
    Ehrt U; Brønnick K; Leentjens AF; Larsen JP; Aarsland D
    Int J Geriatr Psychiatry; 2006 Mar; 21(3):252-8. PubMed ID: 16477585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relation of sexual dysfunction to depression and anxiety in patients with Parkinson's disease.
    Özcan T; Benli E; Demir EY; Özer F; Kaya Y; Haytan CE
    Acta Neuropsychiatr; 2015 Feb; 27(1):33-7. PubMed ID: 25385451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apathy in elderly nondemented patients with Parkinson's disease: clinical determinants and relationship to quality of life.
    Skorvanek M; Rosenberger J; Gdovinova Z; Nagyova I; Saeedian RG; Groothoff JW; Dijk JP
    J Geriatr Psychiatry Neurol; 2013 Dec; 26(4):237-43. PubMed ID: 23970460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-frequency repetitive transcranial magnetic stimulation over the primary foot motor area in Parkinson's disease.
    Maruo T; Hosomi K; Shimokawa T; Kishima H; Oshino S; Morris S; Kageyama Y; Yokoe M; Yoshimine T; Saitoh Y
    Brain Stimul; 2013 Nov; 6(6):884-91. PubMed ID: 23769414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between depressive symptoms and nocturnal disturbances in Japanese patients with Parkinson's disease.
    Suzuki K; Miyamoto M; Miyamoto T; Okuma Y; Hattori N; Kamei S; Yoshii F; Utsumi H; Iwasaki Y; Iijima M; Hirata K
    Parkinsonism Relat Disord; 2009 Jan; 15(1):15-9. PubMed ID: 18359262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nocturnal disturbances and restlessness in Parkinson's disease: using the Japanese version of the Parkinson's disease sleep scale-2.
    Suzuki K; Miyamoto M; Miyamoto T; Tatsumoto M; Watanabe Y; Suzuki S; Iwanami M; Sada T; Kadowaki T; Numao A; Trenkwalder C; Hirata K
    J Neurol Sci; 2012 Jul; 318(1-2):76-81. PubMed ID: 22534309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association of apathy with central fatigue perception in patients with Parkinson's disease.
    Sáez-Francàs N; Hernández-Vara J; Corominas Roso M; Alegre Martín J; Casas Brugué M
    Behav Neurosci; 2013 Apr; 127(2):237-44. PubMed ID: 23339489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS).
    Santangelo G; Falco F; D'Iorio A; Cuoco S; Raimo S; Amboni M; Pellecchia MT; Longo K; Vitale C; Barone P
    J Neurol Sci; 2016 Aug; 367():158-61. PubMed ID: 27423582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability.
    Smith KM; Eyal E; Weintraub D;
    JAMA Neurol; 2015 Jan; 72(1):88-95. PubMed ID: 25420207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.